Your browser doesn't support javascript.
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.
Kaku, Chengzi I; Bergeron, Alan J; Ahlm, Clas; Normark, Johan; Sakharkar, Mrunal; Forsell, Mattias N E; Walker, Laura M.
  • Kaku CI; Adimab LLC, Lebanon, NH 03766, USA.
  • Bergeron AJ; Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA.
  • Ahlm C; Department of Microbiology and Immunology, Dartmouth College, Hanover, NH 03755, USA.
  • Normark J; Division of Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Sakharkar M; Division of Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Forsell MNE; Adimab LLC, Lebanon, NH 03766, USA.
  • Walker LM; Division of Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Sci Immunol ; 7(73): eabq3511, 2022 07 29.
Article in English | MEDLINE | ID: covidwho-2038228
ABSTRACT
Understanding immune responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection will facilitate the development of next-generation vaccines. Here, we profiled spike (S)-specific B cell responses after Omicron/BA.1 infection in messenger RNA-vaccinated donors. The acute antibody response was characterized by high levels of somatic hypermutation and a bias toward recognition of ancestral SARS-CoV-2 strains, suggesting the early activation of vaccine-induced memory B cells. BA.1 breakthrough infection induced a shift in B cell immunodominance hierarchy from the S2 subunit, which is highly conserved across SARS-CoV-2 variants of concern (VOCs), and toward the antigenically variable receptor binding domain (RBD). A large proportion of RBD-directed neutralizing antibodies isolated from BA.1 breakthrough infection donors displayed convergent sequence features and broadly recognized SARS-CoV-2 VOCs. Together, these findings provide insights into the role of preexisting immunity in shaping the B cell response to heterologous SARS-CoV-2 variant exposure.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: B-Lymphocytes / COVID-19 / Immunologic Memory Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Sci Immunol Year: 2022 Document Type: Article Affiliation country: Sciimmunol.abq3511

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: B-Lymphocytes / COVID-19 / Immunologic Memory Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Sci Immunol Year: 2022 Document Type: Article Affiliation country: Sciimmunol.abq3511